Stock futures popped in Tuesday morning trading after inflation cooled unexpectedly in April. The consumer price index for April rose at a 2.3% annual rate, which was below economists' expectations for inflation to hold steady at 2.
Addresses key challenges for CAR-T therapies Potential to significantly reduce costs and improve clinical efficacy of engineered effector T cells Data Shared at 2025 Annual Meeting of American Association of Immunologists MIRAMAR, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by targeting the link between
Favorable demand in major markets for crop nutrients, backed by the strength in global agriculture markets, should enable the Zacks Fertilizers industry to thrive. CF, MOS and YARIY should benefit from supportive industry fundamentals.
GoHealth (GOCO) delivered earnings and revenue surprises of -80.77% and 2.77%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
The round is expected to be led by Accel, with continued backing from Nvidia.
The Dow Jones Industrial Average looked set to open in the red Tuesday after one of its 30 components named a new CEO and suspended its guidance. The blue-chip index was on track to open down 140 points. UnitedHealth stock, down 10% in premarket trading, was on track to shave 214 points off the Dow, putting the index in negative territory on its own.
BABA's AI surge and cloud expansion signal strong Q4 outlook. With record investments and triple-digit AI growth, this undervalued tech giant offers compelling pre-earnings entry.
Water analytics and treatment company Veralto (NYSE:VLTO) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 6.9% year on year to $1.33 billion. On the other hand, next quarter’s revenue guidance of $1.32 billion was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $0.95 per share was 9.4% above analysts’ consensus estimates.
Safety equipment manufacturer MSA Safety (NYSE:MSA) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 1.9% year on year to $421.3 million. Its non-GAAP profit of $1.68 per share was 6.3% above analysts’ consensus estimates.
Nuwellis (NUWE) delivered earnings and revenue surprises of -53.33% and 23.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?